Close X
Friday, November 15, 2024
ADVT 
International

Indian-American admits to promoting illegal charitable contribution tax scheme

Darpan News Desk IANS, 12 Jul, 2023 12:05 PM
  • Indian-American admits to promoting illegal charitable contribution tax scheme

New York, July 12 (IANS) An Indian-American financial planner from Cleveland has pleaded guilty to conspiracy to defraud the US government in addition to aiding and abetting the filing of a false tax return.

Rao Garuda, President and Chief Executive Officer of Associated Concepts Agency (ACA), was accused by federal prosecutors last month of providing a tax shelter for wealthy clients by making it look like they contributed to a charity.

According to court documents and statements made in court, Garuda engaged in a scheme -- Advanced Legacy Plan or the Ultimate Tax Plan -- to assist high-income individuals in unlawfully reducing their taxes using a plan organised, marketed and sold by a co-conspirator.  

ACA’s former Chief Operating Officer previously pleaded guilty to conspiracy to defraud the US on September 26, 2022.

To accomplish the scheme, Garuda, his co-conspirators, and other accomplices instructed clients to transfer assets to an LLC in exchange for 100 per cent ownership interest in the LLC; assign the ownership interest to a charity controlled by co-conspirators, and claim a charitable contribution tax deduction for the purported donation.    

Garuda and others marketed the scheme as a way for clients to receive the tax deduction without relinquishing control over the LLC or its assets, a Department of Justice release stated.  


After executing the scheme, clients could access the assets inside the LLCs through tax-free loans.  


Garuda marketed the scheme despite being warned by several attorneys over the years that the scheme was illegal, such as one attorney describing the scheme as “clearly fraudulent”.

Garuda and the co-conspirator also assisted clients in claiming charitable contribution tax deductions after the close of the tax year by backdating documents to make it look as if clients executed the scheme in a prior year.

To do so, Garuda and others directed clients to use pre-existing LLCs (sometimes referred to as “Shelf LLCs”) that his co-conspirator had created and formed at the end of the prior year and backdate documents to make it appear as if the clients owned and assigned ownership interests in the Shelf LLCs in the prior year.

For his role in the scheme, Garuda caused or intended to cause a tax loss of more than $2.7 million, which he agreed to pay back as restitution to the US.

The Department of Justice filed a civil lawsuit against his co-conspirator in 2018 to stop him from organising, marketing, and selling the scheme.

Following this, Garuda, his co-conspirator and other accomplices sought to obstruct the case by providing clients with false, backdated documents to turn over to the government in response to civil subpoenas.

Garuda is scheduled to be sentenced on November 14, 2023, and faces a maximum penalty of five years in prison for conspiracy to defraud the United States and three years in prison for the false return count.  

He also faces a period of supervised release, restitution, and monetary penalties.  

A federal district court judge will determine any sentence after considering the US Sentencing Guidelines and other statutory factors.

MORE International ARTICLES

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate

Magnitsky sanctions demanded in Iranian shootdown

Magnitsky sanctions demanded in Iranian shootdown
There were 176 people killed when the Iranian military shot down Ukraine International Airlines Flight PS752 on Jan. 8, shortly after it took off from Tehran.

Magnitsky sanctions demanded in Iranian shootdown

Berry scare: U.S. eyeing foreign produce imports

Berry scare: U.S. eyeing foreign produce imports
U.S. Trade Representative Robert Lighthizer served notice last week that the Trump administration fears domestic producers are being unfairly harmed by what they call a recent increase in berry imports from Canada and Mexico.

Berry scare: U.S. eyeing foreign produce imports